後COVID-19時代「中國製造2025」的路線修正與延續

On the possibility of reforming or maintaining“Made in China 2025” in Post-COVID-19 Era

COVID-19 對全球帶來的影響無法計數，各國亦因此做出了不同層面的因應措施，但對於中國大陸而言，在為了提振逐步平緩的經濟，所提出的「中國製造 2025」國家政策，同樣需考量疫情及相關國際情勢的變遷，而有著相對應的修正措施。本文以此為出發點，探討在疫苗問世之後，且疫情也相對平緩的後 COVID-19 時代，「中國製造 2025」該如何做出修正或是延續。

COVID-19 has impacted the global community tremendously, and governments worldwide have implemented various measures to respond to the pandemic. To Mainland China, the national policy “Made in China 2025,” proposed to boost its stagnant economy, must also be revised according to changes brought by the pandemic and relevant international affairs. Accordingly, this study explored the revision and continuation of “Made in China 2025” in the post-pandemic era, in which vaccines have been introduced and the pandemic is relatively held under control.